Request Demo
Last update 30 Jan 2026
Shanxi Yellow River Traditional Chinese Medicine Co., Ltd
Last update 30 Jan 2026
Overview
Tags
Respiratory Diseases
Infectious Diseases
Herbal medicine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20241345
确证性评价山金连软胶囊治疗普通感冒(风热证)安全性与有效性
随机双盲、安慰剂对照、多中心Ⅲ期临床试验
[Translation] Confirmatory evaluation of the safety and efficacy of Sanjinlian soft capsules in the treatment of common cold (wind-heat syndrome)
A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial
CTR20223237
山金连软胶囊治疗普通感冒(风热证)临床安全性与有效性随机、双盲、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, multicenter phase II clinical trial on the safety and efficacy of Shanjinlian soft capsules in the treatment of common cold (wind-heat syndrome)
CTR20200513
山金连软胶囊治疗普通感冒（风热证）临床安全性与有效性随机、双盲、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, multicenter phase II clinical trial on the safety and efficacy of Shanjinlian soft capsules in the treatment of common cold (wind-heat syndrome)
100 Clinical Results associated with Shanxi Yellow River Traditional Chinese Medicine Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Shanxi Yellow River Traditional Chinese Medicine Co., Ltd
Login to view more data
100 Translational Medicine associated with Shanxi Yellow River Traditional Chinese Medicine Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 12 Mar 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free